Report overview
This report contains market size and forecasts of Zika Virus Vaccines in global, including the following market information:
Global Zika Virus Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Zika Virus Vaccines Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Zika Virus Vaccines companies in 2021 (%)
The global Zika Virus Vaccines market was valued at 13420 million in 2021 and is projected to reach US$ 16260 million by 2028, at a CAGR of 2.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DNA Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zika Virus Vaccines include NHI, Sanofi, GSK, Bharat., Takeda, Inovio Pharmaceuticals, GeneOne Life Science Inc, PaxVax and Gilead Sciences Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Zika Virus Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zika Virus Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Zika Virus Vaccines Market Segment Percentages, by Type, 2021 (%)
DNA Vaccine
Inactivated Vaccine
Purified Inactivated Vaccine
Table of Contents
Global Zika Virus Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Zika Virus Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Academic and Research
Others
Global Zika Virus Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Zika Virus Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zika Virus Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Zika Virus Vaccines revenues share in global market, 2021 (%)
Key companies Zika Virus Vaccines sales in global market, 2017-2022 (Estimated), (MT)
Key companies Zika Virus Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
NHI
Sanofi
GSK
Bharat.
Takeda
Inovio Pharmaceuticals
GeneOne Life Science Inc
PaxVax
Gilead Sciences Inc.
Intrexon Corp.
NewLink Genetics Corp
